Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation.
García-Albéniz X, Gallego R, Hofheinz RD, Fernández-Esparrach G, Ayuso-Colella JR, Bombí JA, Conill C, Cuatrecasas M, Delgado S, Ginés A, Miquel R, Pagés M, Pineda E, Pereira V, Sosa A, Reig O, Victoria I, Feliz L, María de Lacy A, Castells A, Burkholder I, Hochhaus A, Maurel J. García-Albéniz X, et al. Among authors: burkholder i. World J Gastroenterol. 2014 Nov 14;20(42):15820-9. doi: 10.3748/wjg.v20.i42.15820. World J Gastroenterol. 2014. PMID: 25400468 Free PMC article.
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
Hofheinz RD, Wenz F, Post S, Matzdorff A, Laechelt S, Hartmann JT, Müller L, Link H, Moehler M, Kettner E, Fritz E, Hieber U, Lindemann HW, Grunewald M, Kremers S, Constantin C, Hipp M, Hartung G, Gencer D, Kienle P, Burkholder I, Hochhaus A. Hofheinz RD, et al. Among authors: burkholder i. Lancet Oncol. 2012 Jun;13(6):579-88. doi: 10.1016/S1470-2045(12)70116-X. Epub 2012 Apr 13. Lancet Oncol. 2012. PMID: 22503032 Clinical Trial.
Height of Rectal Cancer: A Comparison between Rectoscopic and Different MRI Measurements.
Attenberger UI, Winter J, Harder FN, Burkholder I, Dinter D, Kaltschmidt S, Kienle P, Schoenberg SO, Hofheinz R. Attenberger UI, et al. Among authors: burkholder i. Gastroenterol Res Pract. 2020 Jan 28;2020:2130705. doi: 10.1155/2020/2130705. eCollection 2020. Gastroenterol Res Pract. 2020. PMID: 32411193 Free PMC article.
Influence of complete administration of adjuvant chemotherapy cycles on overall and disease-free survival in locally advanced rectal cancer: post hoc analysis of a randomized, multicenter, non-inferiority, phase 3 trial.
Sandra-Petrescu F, Herrle F, Burkholder I, Kienle P, Hofheinz RD. Sandra-Petrescu F, et al. Among authors: burkholder i. BMC Cancer. 2018 Apr 3;18(1):369. doi: 10.1186/s12885-018-4309-6. BMC Cancer. 2018. PMID: 29614991 Free PMC article. Clinical Trial.
Adjuvant chemotherapy for rectal cancer.
Hofheinz RD, Rödel C, Burkholder I, Kienle P. Hofheinz RD, et al. Among authors: burkholder i. Lancet Oncol. 2015 Apr;16(4):e154-5. doi: 10.1016/S1470-2045(15)70112-9. Lancet Oncol. 2015. PMID: 25846090 No abstract available.
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.
Steinbild S, Mross K, Frost A, Morant R, Gillessen S, Dittrich C, Strumberg D, Hochhaus A, Hanauske AR, Edler L, Burkholder I, Scheulen M. Steinbild S, et al. Among authors: burkholder i. Br J Cancer. 2007 Dec 3;97(11):1480-5. doi: 10.1038/sj.bjc.6604064. Epub 2007 Nov 27. Br J Cancer. 2007. PMID: 18040273 Free PMC article. Clinical Trial.
Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval.
Gencer D, Al-Batran SE, Dada R, Hünerlitürkoglu AN, Gonnermann M, Kegel T, Scheiber H, Jordan WO, Burkholder I, Kellermann L, Hofheinz RD. Gencer D, et al. Among authors: burkholder i. J Cancer Res Clin Oncol. 2013 Feb;139(2):337-45. doi: 10.1007/s00432-012-1335-7. Epub 2012 Oct 19. J Cancer Res Clin Oncol. 2013. PMID: 23080134
Reply to S. Iwase et al.
Hofheinz RD, Burkholder I, Schneeweiss A. Hofheinz RD, et al. Among authors: burkholder i. J Clin Oncol. 2016 Feb 1;34(4):392. doi: 10.1200/JCO.2015.64.8402. Epub 2015 Nov 30. J Clin Oncol. 2016. PMID: 26628462 No abstract available.
A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.
Bergmann L, Maute L, Heil G, Rüssel J, Weidmann E, Köberle D, Fuxius S, Weigang-Köhler K, Aulitzky WE, Wörmann B, Hartung G, Moritz B, Edler L, Burkholder I, Scheulen ME, Richly H. Bergmann L, et al. Among authors: burkholder i. Eur J Cancer. 2015 Jan;51(1):27-36. doi: 10.1016/j.ejca.2014.10.010. Epub 2014 Nov 5. Eur J Cancer. 2015. PMID: 25459392 Clinical Trial.
58 results